跳至主要内容
临床试验/IRCT2016051027832N1
IRCT2016051027832N1已完成2 期

Melatonin attenuates antipsychotic metaboliceffects:

Kashan University of Medical Sciences0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 64 years(—)
性别
All

入选标准

  • men and women 18 to 64 years old who have recently been treated with second-generation antipsychotics; Exclusion criteria: patients with high blood pressure, diabetes, lipid disorders, thyroid disorders and liver diseases; a history of sensitivity to melatonin; high risk of suicide or aggression; pregnant women or lactating; patients at any time during the study drugs antipsychotic abandoned or Do not take two doses of melatonin pill; substance Abuse or dependence in the last 6 months;

排除标准

  • 未提供

研究者

相似试验